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Ethnopharmacological Relevance. Malaria is one of the lethal diseases of man, contributing to about 17 million deaths annually,
leading to sociocultural, economic, and health influences. Aim of the Study. *e study explores the ethnobotanical and eth-
nopharmacological appraisal of antimalarial plants used by people of OmuAran, Ogbomoso, Ado Ekiti, and Sagamu communities
in Nigeria. Materials and Methods. For this study, relevant information was procured from the inhabitants via a structured
questionnaire to procure the general knowledge of antimalarial medicinal plants. Results and Discussion. A total of 90 interviewees
(44 men and 46 women) were involved in this survey. A total of 59 medicinal species were identified, which were dispersed in 33
families (Asteraceae (6), Apocynaceae (5), Anacardiaceae, Annonaceae, Fabaceae, Malvaceae, Meliaceae, Poaceae, and Rubiaceae
(3 each), Phyllanthaceae (2)) totaling 49% of the cited species. *emost cited plants are Azadirachta indica (42),Mangifera indica
(38),Carica papaya (28),Cymbopogon citratus (27),Cassia fistula (15),Morinda lucida (14),Anacardium occidentale and Vernonia
amygdalina (13 each), Helianthus annuus (11), Enantia chlorantha (10), and Moringa oleifera (9) A total of 105 citations were
recorded for the plant parts used (leaf (46), bark (17), fruits (9), root (9), latex (11), stem (11), and inflorescence (2)) while
decoction (59%), maceration (25%), infusion (9%), and exudation (7%) were the methods of preparation. Use Values (UVs) of
0.47 to 0.11 were recorded for the frequently used antimalarial plants. *e Efficiency Levels (ELs) of 11 different medicinal plants
stated by the respondents were Azadirachta indica, Cassia fistula andMorinda lucida (12), Chromolaena odorata (10),Mangifera
indica, Enantia chlorantha and Helianthus annuus (8), Cymbopogon citratus (7), Gossypium arboretum (4), Landolphia dulcis (3),
and Aloe vera (2) Cocos nucifera, Curcuma longa, Forkia biglobosa, and Musa acuminate are mentioned for the first time in the
study area with little or no reported antiplasmodial activities. Conclusion. *e study appraised the commonly used antimalarial
plants in the study areas. *erefore, commitment to scientifically explore the bioactive compounds, antimalarial potential and
toxicological profile of these plants is inevitable as they could lead to novel natural products for effective malaria therapy.
1. Introduction
Malaria is one of the communal diseases of man contrib-
uting to stern sociocultural, economic, and health influences
in humid, middle-income nations, sub-Saharan Africa,
Southeast Asia, and South America [1, 2]. It is instigated by
Plasmodium ovale, P. malariae, P. falciparum, P. vivax, and
P. knowlesi [3]. *e outburst of malarial infections in Africa,
the Caribbean, Asia, and South American is symptomatic of
P. falciparum, the most lethal malaria parasite. *e parasite
could accumulate in the brain capillaries [4, 5]. Malarial
infections in India, Central American, and East Mediter-
ranean could be concomitant to P. vivax while P. ovale and
P. malariae are prevalent in Papua New Guinea and sub-
Saharan Africa [6].
Malaria epidemic has been enormously high in low
socioeconomic empowered regions. In Africa, nearly 19
million cases of malaria infections have been reported ac-
counting to 89% of the global cases and almost 17 million
deaths have been published [7]. Also, about 450 thousand
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African children’s deaths have been reported and one-tenth
of pregnancy deaths have been concomitant to malaria
infections [2, 8]. It affected the morbidity and mortality rate
owing to pathogenic resistance to conventional drugs, vector
control agents, and human migration [9]. Several factors
have been analysed and reported to control malaria infec-
tions in Africa. *ese are climate suitability, dams or res-
ervoirs, migration, and vegetation. According to the report
published by*eWorld malaria in 2018, malarial cases have
tremendously reduced in relation to the report of 2010.
Despite this, between 2015 and 2017, no significant progress
was achieved in curbing malaria cases [10]. *is trend could
be indicative of the widely spread of drug-resistant malaria
and the intricacy of parasites’ life cycle [11].
Quinoline (QN) derivatives are undoubtedly the com-
monest antimalarial drugs in Africa. Examples of quinoline
antimalarial drugs are quinine, amodiaquine, piperaquine,
primaquine, pyronaridine, ferroguine, isoquine, amopyr-
oquine, tertbutylisoquine, mefloquine, tafenoquine, and
chloroquine. 4-Aminoquinoline is the most accessible an-
timalarial pharmacophore used in the last century. In recent
times, QN derivatives have been integral component of
Artemisinin-based Combination *erapy (ACT) [12]. *e
discovery of ACT could be considered as the most note-
worthy achievement of ethnopharmacological research in
the 20th century [13–15], enthused by the use of Artemisia
annua L. (Asteraceae). *e drug was found effective against
all the malarial parasites and led to regulations against
quinine-based drugs in Africa. However, despite the pre-
dominant achievements of ACT, concerns about the future
efficacy of artemisinin have recently been on the rise due to
the building-up of resistance by the parasite [7]. *is event
instigates the unrelenting search for promising antimalarial
drugs that are cost-effective, handy, acceptable, and scien-
tifically proven.
Human has used medicinal plants for malaria, cholera,
yellow fever, and diabetes treatment [16]. In most African
countries, medicinal herbs are viewed as alternative thera-
pies. Medicinal plants have effectively helped in primary
health care for the therapy of acute and chronic diseases
[17, 18]. *ey have contributed to the discovery of novel
therapeutic agents via isolation, identification, and charac-
terization of secondary metabolites [19]. Secondary me-
tabolites such as flavonoids, stilbenes, coumarins, lignin,
tannins, terpenoids, and steroids have been reported as
antimalarial compounds [20].
Tropical plants are identified to contain high proportions
of natural chemical compounds and a greater diversity than
plants from any other biome. *us, they are potential
sources of new medicines [21]. *e increased number of
drug-resistant strains makes the development of novel an-
timalarial urgent. *e high cost of malaria treatment has left
the poor masses of Nigeria heavily reliant on traditional
practitioners and medicinal plants for the treatment of the
disease. It seems logical to encourage studies on plants from
these regions, especially since the major proportions of
malaria attributable deaths occur in sub-Saharan African
regions. Although several compounds had achieved success
at treating malaria diseases, the emerging threats of drug
resistance by some plasmodium species call for the devel-
opment of new molecules with novel bioactive features. *e
study explores the ethnobotanical and ethno-
pharmacological appraisal of antimalarial plants used by
people of Omu Aran, Ogbomoso, Ado Ekiti, and Sagamu
communities in Nigeria. Hence, the search for novel natural
antimalarial molecules in selected plant sources via ethno-
botanical and ethnopharmacological investigation is clearly
justified.
2. Methodology
2.1. Geographical Description of the Study Area. *e study
area comprises four states, namely, Kwara (Omu Aran), Oyo
(Ogbomoso), Ekiti (Ado Ekiti), and Ogun (Sagamu) in
Nigeria located on 8°08′N (5°06′E), 8°08′N (4°15′E),
7°37′16″N (5°13′17″E), and 6°50′N (3°39′E), respectively.
*e study areas are located in two important geopolitical
zones, that is, Omu Aran (North central), Ogbomoso,
Sagamu, and Ado Ekiti (Southwest) of Nigeria (Figure 1)*e
inhabitants are majorly from the Yoruba ethnic group. *e
study area falls into the category of state with most prev-
alence of malaria in Nigeria according to MIS report.
2.2. Typical Vegetation of the Study Area. Ado Ekiti and
Sagamu fall in the rain forest region, characterized by
temperature of 21° to 28°C, high humidity, and two distinct
seasons, rainy season from April to October and dry season
from November to March with mean annual rainfall of
1320mm. Ogbomoso and Omu Aran fall in the savanna
region, characterized by temperature of 21° to 33°C with
heavy rainfall between April and October. *e humidity is
high (51.1%) with mean annual rainfall of 1885mm. *e
study sites are opulently rich in evergreen floras and this
promotes the use of local herbs for diseases prevention and
cure.
2.3. Selection of the Informants. For this study, relevant
information and data were procured from selected people in
the study area via interview using structured questionnaire
to procure relevant knowledge of antimalarial plants used in
the vicinity. *e questions were structured in a simple way
and interpreted to selected respondents selected by nomi-
nation method after verbal authorization and approval by
the chiefs in the study areas. In a particular study area, the
leaders suggested prominent people with vast experience in
herbal medicines or practitioners of herbal medicines. For
reliability and reproducibility, respondents that accepted to
be interviewed were briefed on the significance and objec-
tives of the study. A disclaimer was presented to the in-
terviewees that the views, ideas, and opinions expressed
belong solely to the interviewers, and not necessarily to any
committee or individual. While conducting the research,
researchers were honest but not too detailed in briefing the
respondents what he or she needed to do. Conducting the
survey involved series of activities. *ese include estab-
lishing cordial relationship with respondents, selecting easy
ways of interacting, observation, and recording the findings.
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Respondents selected must meet the following criteria:
(1) they should be indigenous people of Yoruba; (2) they are
sound and knowledgeable in phytotherapy; (3) they are
accessible to medicinal plants; (4) they must have used herbs
for treating malaria; (5) they are approachable and
organized.
2.4. Structured Questionnaire. *e structured questionnaire
was designed according to the technique of Olorunnisola
et al. [22] and Sarquis et al. [23] with slight modification.*e
moderated questionnaire entails information on respondent
biodata, commonly used antimalarial medicinal plants, plant
parts frequently used, the most effective herbs from the
respondents list, mode of preparation, and common side
effects of antimalarial plants.
2.5. Data Collection. *e study was piloted for 6 months,
fromMarch to August 2019.*emode of data collection was
through one-on-one interviews, public discussion, and
observation. *e interviews were conducted mostly in
Yoruba (native) language. *e respondents gave the native
names of plants and showed the interviewers the available
plant samples. Information on the questionnaires was
supplied on the spot of interview, and several observations
and discussions were conducted prior to completing and
cross-checking of the information provided.
2.6. Data Analysis. *e antimalarial medicinal plants
itemized by the respondents were structured according to
the scientific, common, and local names, family, plant part
used, and mode of preparation. *e malarial diseases’
symptoms and probable health effects or body reactions
were reported. Data were statistically analysed in percent-
ages using Graphpad Prism software (version 6.0) *e
comparative significance of a plant species for its ethno-
pharmacological activity was evaluated with the Index of Use
Value (UV) and efficiency level (EL).
2.6.1. Use Value (UV). It is a quantifiable catalogue that
denotes the therapeutic importance of each medicinal plant
species. It is calculated by UV�ΣUi/n, where Ui is the total
number of times plant species is cited and n is the total
number of respondents interviewed. UV element helps
evaluate plant species frequently mentioned for antimalaria.
A high UV denotes plant mentioned mostly by respondents
and low for sparingly mentioned [23].
2.6.2. Efficiency Level (EL). It is a qualitative index that
signifies the efficacy of a single plant species from the list of
plants given as a response by the interviewees. EL is cal-
culated by CL�Ui, where Ui is the total number of times a
particular plant species is mentioned as the most effective
from the list of plant species level. EL indicates plant species
showing the most effective therapeutic potentials. A high EL
denotes the most efficacious plant.
3. Results and Discussion
3.1.;eDemographic Details of the Informants. A total of 90
interviewees (44 men and 46 women) were involved in this
ethnobotanical and ethnopharmacological survey. Demo-
graphic details of the interviewees are listed in Table 1. *e
respective age distribution and the level of education of the
respondents are shown in Figure 2.
3.2.;eEffectiveness of theMedicinal Plants. In this study, 57
respondents (63%) strongly agreed and 26 respondents
(29%) agreed that malaria is curable using medicinal herbs
while 7 respondents (8%) were neutral.*is denotes the local
belief in phytotherapy of malaria. *e study site has rich
vegetation diversity ranging from creeping plant to shrubs
and trees. A large number of these plants are used by the
inhabitants in malaria therapy due to persistent spread of
malaria in these regions.
3.3. Indigenous Notion of the Study Area on Malaria. *e
common symptoms of malaria and side effects of antima-
larial plants according to the native knowledge of Ado Ekiti,
Ogbomoso, Omu Aran, and Sagamu people are detailed in
Table 2. Yoruba people identify malaria as “iba” and pre-
sumed malaria as a common and seasonal disease. From
one-on-one interview and observations, malaria prevalence
is significantly high during the rainy season in the study
areas. According to the respondents, malaria is caused by
long-time exposure to rain, cold, hot sun, stress, and
mosquito. *ey believed that these could disrupt the tem-
perature balance in the body.
Likewise, the respondents were screened to procure
knowledge of malaria via the common symptoms they ex-
perienced (Figure 3) Fever, body pain, fatigue, and headache
are the common symptoms in the study area and are related
to temperature balance of the body system. *e local people
believed that it could be caused by excessive heat and long-
time exposure to cold environment which forces the body to























Figure 1: Map of Nigeria showing the study area.
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could lead to other symptoms such as headache, fatigue,
body pain, and sweating. According to the respondents,
probable ways of preventing malaria include reduction in
exposure to rain (cold areas) or sun (hot areas), avoidance of
mosquito bites, reduction in workload (stress), constant use
of antimalarial herbal drugs, and burning of aromatic an-
timalarial plants which could pose threats to mosquitoes.
Medicinal plants are universally reported to produce
uncharacteristic effects ranging from simple to intricate. *e
respondents were screened to procure information on
common health effects associated with antimalarial herbal
drugs. Several reports were obtained, grouped as dizziness,
sweating, weakness, frequent urination, itching, and no side
effects (Figure 4) However, 15 (70%) respondents cited other
effects produced by medicinal plants on their body systems.
*e respondents believed that these effects are related to the
nature of medicinal plants combined, quantity of herbs
taken, period when herb is used, temperature of herbal drugs
(warm or cold), season drugs are taken, severity of malaria,
and body capacity.
3.4.Assortment ofAntimalarial;erapeuticPlants. A total of
59 medicinal plants were cited which belong to 33 families.
*ese are Asteraceae (6), Apocynaceae (5), Anacardiaceae,
Annonaceae, Fabaceae, Malvaceae, Meliaceae, Poaceae and
Rubiaceae (3 each), Phyllanthaceae (2) totaling 48.83% of the
sampled species while Asteraceae, Arecaceae, Asphodela-
ceae, Boraginaceae, Bromeliaceae, Caricaceae, Crassulaceae,
Lamiaceae, Lythraceae, Menispermaceae, Moringaceae,
Musaceae, Rutaceae, Sapindaceae, Myrtaceae, Solanaceae,
Zingiberaceae, Solanaceae, Meliaceae, *eaceae, Labiatae,
Hymenocardiacae, and Zingiberaceae accounted for 22.5%
of families mentioned once (Table 3) *e most cited plants
include Azadirachta indica (42), Mangifera indica (38),
Carica papaya (28), Cymbopogon citratus (27), Cassia fistula
(15), Morinda lucida (14), Anacardium occidentale and
Vernonia amagdalina (13 each), Helianthus annuus (11),
Enantia chlorantha (10), Moringa oleifera (9), Chromolaena
odorata, and Psidium guajava (7 each)*e efficacy of a plant
species is evidenced in its number of citations, thus, be-
coming spotlight in pharmacological research leading to the
discovery of novel antimalarial drugs. However, we cannot
rule out the possibility of cultural factors unrelated to ef-
ficacy as having impacted the citation rate.
3.5. Used Medicinal Plant Parts. *e commonest used parts
cited are leaf (46), bark (17), fruits (9), root (9), latex (11),
stem (11), and inflorescence (2) (Figure 5)Many antimalarial
herbal drugs are commonly prepared from a single plant
part, although they could be prepared from the assortment
of two or more plant parts. In this survey, leaf and bark were
the most cited plant parts contributing to 255 and 101 of the
480 plant parts cited by the respondents. Leaves are the most
commonly used plant parts in Nigeria [24, 25]. *is could be
due to the simplicity of the collection, site of synthesizing
majority of plant secondary metabolites, and diverse bio-
active compounds appraised by preliminary phytochemical
investigations of leaves [26–28]. Systematic harvest of leaves
has little or no influence on plants survival. *is explains the
frequent utilization of leaves in herbal recipes [29, 30].
3.6. Forms ofHerbalDrugs’ Preparations forMalaria;erapy.
*e common herbal drugs’ preparations according to the
study were categorized as decoction, maceration, infusion,
and exudation (Table 3) *e most cited methods of prep-
aration are decoction (59%), maceration (25%), infusion
(9%), and exudation (7%) (Figure 6) Decoction was cited 99
times; maceration, 65 times; infusion, 35 times; and exu-
dation, 13 times. Decoction is commonly used in herbal
recipes because recipe could be stored, could have long-life
span, could be taken orally, and could be used as bath. Due to
heat treatment, recipe is safe to administer and more me-
tabolites are believed to be extracted. Maceration is also
Table 1: Demographic details of the informants (N� 90).
Biodata Group of informants No of informants, n (%)
Age
20–39 years old 49 (54.44)
40–59 years old 22 (24.44)
60–79 years old 15 (16.67)
>80 years old 04 (4.44)
Sex Male 44 (48.88)Female 46 (51.11)
Education
Illiterate (none) 16 (17.78)
Primary level 07 (7.78)
Secondary level 23 (25.56)
Tertiary level 44 (48.89)
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Figure 2: Age distribution and level of education of the
respondents.
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common among the Yorubas. It involves permeation of the
plant materials (mostly bark and root) in aqueous (water) or
organic (alcohol) solvents.
3.7. Assessment of the Different Indexes. In this study, UVs
within 0.47 and 0.11 is appraised as frequently used anti-
malarial plants by the Yorubas: Azadirachta indica (0.47),
Mangifera indica (0.42), Carica papaya (0.31), Cymbopogon
citratus (0.3), Cassia fistula (0.17), Morinda lucida (0.16),
Anacardium occidentale (0.14), Vernonia amagdalina (0.14),
Helianthus annuus (0.12), and Enantia chlorantha (0.11)
(Table 3) *e most significant plant species are those with
high UV and should be compiled for preservation.
*e EL appraised the efficacy of a particular plant from
the catalogue given by the interviewees. In this study, 11
different medicinal plants were mentioned by the respon-
dents as most efficacious from array of medicinal plants
listed. 26 respondents cited A. indica and C. fistula whileM.
lucida was cited by 12 respondents; C. odorata, 10 re-
spondents; M. indica, E. chlorantha, and H. annuus, 8 re-
spondents each; C. citratus (7 respondents); G. arboretum, 4
respondents; L. dulcis, 3 respondents; and A. vera, 2
respondents.
*e in vitro and in vivo antiplasmodial potency of
medicinal plants has been appraised against P. falciparum, P.
berghei, and P. yoelii. Some of the plants with exceptional
antiplasmodial activities are P. guajava [31], N. latifolia [32],
C. citratus [33, 34],U. chamae [35], E. chlorantha [36, 37],O.
gratissimum [38], A. leiocarpus [39], P. amarus [40], A.
indica [41, 42], C. odorata [43, 44], M. lucida [45, 46], V.
amygladina [47], A. boonei 44, 48], A. senegalensis [48], A.
occidentale [49, 50], B. ferruginea [51], G. arboretum [48],M.
oleifera [39], and S. jollyanum [44].
About four plant species are mentioned for the first time
as antimalarial medicinal plant. *ese plants have a low UV
indicating that there is little awareness on these plants in the
region. *e plants are Cocos nucifera (0.01), Curcuma longa
(0.01), Forkia biglobosa (0.01), and Musa acuminate (0.01).
3.8. Antimalarial Assays of Medicinal Plants. Herbal plants
are essential part of biodiversity which have proven to ease
and remediate several diseases and infections. In tropical
African countries, herbal medicine has been an undisputable
therapeutic medium as alternative to conventional medicine
[52]. In view of this, therapeutic potentials of medicinal
Table 2: *e common symptoms of malaria and the health effects of antimalarial herbal drugs.
Common symptoms of malaria No of informants, n (%) Health effects of antimalarial herbal drugs No of informants, n (%)
Fever 25 (28) Dizziness 16 (18)
Fatigue 33 (37) Sweating 44 (49)
Body pain 58 (64) Weakness 22 (6)
Vomiting 6 (7) Frequent urination 24 (5)
Sweating 26 (29) Itching 5 (6)
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Figure 4: Health effects of antimalarial herbal drugs.
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Table 3: *e medicinal plants used as antimalarial in Nigeria (Omu Aran, Ogbomoso, Ado Ekiti, and Sagamu).
Botanical name Local name(s) Family name Parts used Common method ofpreparation
(1) Acanthospermum hispidum (starburr, goat
head) Dagunro Asteraceae Stem, leaves Decoction, maceration
(2) Ageratum conyzoides (billygoat-weed,
goatweed, chickweed, whiteweed) Imi-esu Asteraceae Leaves Decoction
(3) Anogeissus schimperi Ayin Combretaceae Leaves, bark Decoction, maceration
(4) Aloe vera (Aloe) Ahon erin Asphodelaceae Leaves Exudate
(5) Alstonia boonei (cheese wood, stool wood) Ahun Apocynaceae Bark, root Decoction, infusion
(6) Anacardium occidentale (cashew) Kasu Anacardiaceae Stem, leaves,bark
Decoction, infusion,
maceration
(7) Ananas comosus (pineapple) Eso alade, ope oyinbo Bromeliaceae Unripe fruit Exudate, decoction
(8) Annona senegalensis (African custard apple,
wild soursop) Arere Annonaceae Root Infusion, maceration
(9) Azadirachta indica (neem, Indian lilac,





(10) Bridelia exaltata (scrub ironbark, brush
ironbark) Ira, iran oda, ira eju Phyllanthaceae Bark Decoction, maceration
(11) Bryophyllum pinnatum (cathedral bells,
miracle leaf, life plant) Abamoda Crassulaceae Leaves Decoction
(12) Calotropis procera (sodom apple, rubber
bush) Bomu-bomu Apocynaceae Leaves, fruit Decoction, exudate
(13) Camellia sinensis (tea bush) Werepe *eaceae Leaves Decoction
(14) Capsicum frutescens (chili pepper) Ata-ijosi, ata-wewe Solanaceae Seed/fruit Maceration, exudate
(15) Carica papaya (pawpaw) Ibepe Caricaceae Fruit, leaves,root Infusion, maceration
(16) Cassia fistula (golden shower, Indian
laburnum) Igi kasia Fabaceae
Stem, leaves,
bark Decoction, infusion
(17) Ceiba pentandra (kapok tree) Iroko Malvaceae Leaves Decoction
(18) Chromolaena odorata (siam weed, devil
weed, Christmas bush) Ewe akintola, awolowo, Asteraceae Leaves, stem Decoction
(19) Citrus aurantifolia (lime, key lime, west
Indian lime, bartenders lime) Orombo Rutaceae Leaves, fruit Decoction, exudates
(20) Citrus aurantium (sour orange, bigarade
orange, bitter orange) Osan jagan Rutaceae Leaves, fruit Decoction, exudates
(21) Citrus limon (lemon) Osan wewe, ilamuna Rutaceae Stem, root,leaves, fruit Decoction,
(22) Citrus paradise (grape) Ajara Rutaceae Fruit Exudates
(23) Cocos nucifera (coconut) Agbon Arecaceae Fruit shell Decoction, infusion
(24) Curcuma longa (turmeric) Ata-ile pupa Zingiberaceae Fruit Decoction, maceration
(25) Cymbopogon citratus (lemongrass, Malabar
grass)
Oka oyinbo, ewe tea,
koko oba Poaceae Leaves, Decoction
(26) Enantia chlorantha (African yellow wood) Awopa, dokita igbo, osupupa Annonaceae Leaves, bark Decoction, maceration
(27) Parkia biglobosa (African locust bean,
eggplant) Igi iru, sumbala Fabaceae Leaves, bark Decoction, maceration
(28) Gardenia ternifolia Oruwon, Gangan Rubiaceae Leaves Decoction
(29) Gongronema latifolium (bush buck) Arokeke Apocynaceae Leaves, bark Decoction, maceration
(30) Gossypium arboretum (cotton plant) Owu Malvaceae Leaves Decoction
(31) Helianthus annuus (sunflower) Fufulele, June 12,agunmoniye Asteraceae Leaves Decoction,
(32) Heliotropium indicum (Indian heliotrope,
turnsole, English combs comb)






(33) Hibiscus sabdariffa (Roselle, carcade) Zobo Malvaceae Flower Decoction, infusion
(34) Hoslunda opposite Efirin Labiatae Leaves Decoction
(35) Hymenocardia acida Aboopa, orupa Hymenocardiacae Leaves Decoction
(36) Khaya grandifoliola (African mahogany) Oganwo Meliaceae Bark Maceration
(37) Lactuca canadensis (Canada lettuce, tall
lettuce) Yanrin Asteraceae Leaves Decoction
(38) Landolphia dulcis Ibobo, ibo Apocynaceae Leaves Decoction
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plants are appraised against numerous diseases such as
malaria, diabetes, cancer, ulcer, hypertension, and viral
infections [53]. Generally, pharmacological activities of
medicinal herbs could be linked to the existence of sec-
ondary metabolites like cardiac glycosides, saponins, tan-
nins, flavonoids, terpenoids, and alkaloids [18]. Several
plants have been explored for their antimalarial potency with
curative basis exploited from ethnopharmacological beliefs
(Table 4) [76].
Cymbopogon citratus. Lemongrass (Poaceae) is a perennial
grass, evenly distributed in the tropic region, South and
Central America, and has an outstanding profile in the folk
medicine [17]. *e antimalarial potential of aqueous leaf
extracts of C. citratus assessed on twenty-five Swiss albino
mice demonstrated significant prophylactic and chemo-
therapeutic potency against mice infected with 0.2ml O+
human parasitized blood of P. falciparum after 72 h. Sig-
nificant inhibition was observed in parasitaemia level of
blood of infected mice [55]. A larvicidal test of geranial, an
essential oil in C. citratus, was evaluated against Anopheles
funestus (mature larvae) and P. falciparum according to the
WHO standard procedure. Prominent activities were
recorded at LD50 (35.5 ppm and 34.6 ppm) after 6 h. Geranial
also displayed significant antiplasmodial activity with IC50
Table 3: Continued.
Botanical name Local name(s) Family name Parts used Common method ofpreparation
(39) Lawsonia inermis (Henna, Egyptian privet,
cypress shrub) Laali Lythraceae Leaves Decoction
(40) Lecaniodiscus cupanioide Akika Sapindaceae Leaves Decoction
(41) Mangifera indica (mango) Mangoro, oro Anacardiaceae Bark, stem,leaves
Decoction,
maceration, infusion
(42) Morinda lucida (brimstone-tree) Oruwo Rubiaceae Leaves Decoction
(43) Moringa oleifera (moringa, drumstick) Ewe ile, igbale igi iyanu Moringaceae Leaves, bark Decoction, maceration
(44) Musa acuminate (banana) Ogede Musaceae Leaves Decoction
(45) Nauclea latifolia (African peach) Egbo igbesi Rubiaceae Leaves, rootbark Decoction
(46) Ocimum gratissimum (clove basil, scent
plant, African basil) Efirin, aramogbo Lamiaceae Leaves, stem Decoction
(47) Panicum miliaceum (proso millet, hog
millet) Poporo oka, oka baba Poaceae Stem Decoction, maceration
(48) Parquetina nigrescens Igi ogbo Apocynaceae Leaves Decoction
(49) Pennisetum purpureum (elephant grass,
napier grass, Uganda grass) Eèsún, eèsún funfun Poaceae Leaves Decoction
(50) Phyllanthus amarus Eyin olobe Phyllanthaceae Leaves Decoction
(51) Senna alata (candle bush, candletree) Asunwon oyinbo Fabaceae Leaves, flower,fruit Decoction, maceration
(52) Sorghum bicolor (durra, great millet,
jowari) Poroporo okababa Poaceae Stem Decoction
(53) Sphenocentrum jollyanum Aduro koko, akerejupon Menispermaceae Root Decoction, maceration
(54) Spondias mombin (yellow mombin, hog
plum) Okika, akika, iyeye Anacardiaceae Leaves Decoction
(55) Swietenia mahagoni (mahogany) Meliaceae Bark Decoction, maceration
(56) Tridax procumbens (coatbuttons, tridax
daisy) Igbalode, muwagun Asteraceae Leaves Decoction
(57) Uvaria chamae (finger root, bush banana) Eru, eruju, akisan, oko aja Annonaceae Stem, leaves,bark Decoction, maceration
(58) Vernonia amygdalina (bitter leaf ) Onugbo, ewuro Asteraceae Leaves, root, Decoction, maceration
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(4.2± 0.5l g/mL) when assessed by the radioisotopic method.
Geranial could serve as effective natural biocides for com-
bating the larvae of malaria vectors [61]. *e antiplasmodial
activity of aqueous leaf and root extracts of C. citratus (200,
400, and 800mg/kg) and chloroquine (5mg/kg) was ex-
amined against P. berghei in mice using 4-day suppressive
test model atP< 0.05. A dose-dependent suppressive pattern
was observed with chloroquine and 800mg/kg (aqueous
root extract) [67]. C. citratus plant displayed significant
antimalarial activity than herbal concoction or chloroquine
(3200mg/kg) (control) when used as a prophylactic treat-
ment against CBA/Ca mice with patent P. berghei ANKA or
P. chabaudiAS at doses of 1600 and 3200mg/kg. In addition,
the synergetic activity of chloroquine and C. citratus plant
exhibited high activity than chloroquine alone against P.
berghei. *e antimalarial activity of entire C. citratus plant
aids inevitable efforts to developing whole plant remedies for
the treatment of malaria [65].
Morinda lucida. *e antimalarial investigation of partly
purified cysteine-stabilised peptide extracts ofM. lucida leaf
was assessed in vitro against P. falciparum W2 and its ac-
tivities on certain liver and erythrocyte antioxidant pa-
rameters in P. berghei NK65-infected mice. Low activities
were observed in P. falciparum W2 (IC50: >50 μg/ml);
however, in vivo activity against P. berghei led to 51.52%
reduction in parasitaemia on 96 h after inoculation and
considerably decreased (P< 0.05) malondialdehyde con-
centrations in the liver and erythrocyte at high doses in
contrast to untreated controls [60]. N-Hexane and chloro-
form fractions of M. lucida leaf extract conducted using
standard techniques showed significant activities at 0.6mg/
ml [64]. *e antimalarial activities of M. lucida investigated
in P. berghei-infected mice exhibited dose-dependent che-
mosuppression of 39.8–90.5 which show pronounced ac-
tivities than quinine [58].
Enantia chlorantha. Enantia chlorantha Oliver (or
Annickia chlorantha) belongs to Annonaceae family, so-
called Awopa, Osu pupa or Dokita igbo, Eru meru,
Kakerim, and Erenba-vbogo in Nigeria. It is dense and
widely distributed in Nigeria, Angola, Gabon, Cameroon,
and Congo [77]. Oral administration of aqueous extract of
E. chlorantha inhibited Plasmodium yoelii in mice at 0.2 to
150mg/ml while ethanolic extract inhibited the parasite at
dose of 0.05 to 0.5mg/g.*e ethanolic and aqueous extracts
have ED50 values of 0·34mg·g−1and 6·9mg·g−1 which are
schizonticidal in the mode of action. *e activities could be
linked to the presence of saponins, tannins, simple sugars,
and alkaloids [78]. Synergic reactions of E. chlorantha with
N. latifolia and A. altiliswere reported to display significant
antimalarial and prophylactic activities. *is justifies the
ethnomedical practice of combination of antimalarial
herbal therapies in combating acute or chronic malaria
[63].
Aloe vera. *emethanolic extracts ofAloe verawere assessed
in vivo for its antiplasmodial potency against P. falciparum
strain with 50% inhibition of 32 to 77 μg/ml. *e anthrone
C-glucoside homonataloin isolated inhibited the strains with
activity of 13.46± 1.36 μg/ml (IC50); similarly, homonataloin
displayed activities of 107.20± 4.14 μg/ml (IC50) [79].
C-glycosylated anthrones, that is, nataloin and 7-hydrox-
yaloin, two isolated compounds in Aloe pulcherrima, dis-
played significant dose-independent activities on plasmodia
strain using 4-day suppressive test. Pronounced activity of
56.2% was observed at 200mg/kg/day in 48 h, which support
the ethnomedical claims of the plant [80].
Carica papaya. *e antimalarial property of Carica
papaya leaf extracts was screened against P. falciparum 3D7
and Dd2 strains using bioassay-guided fractions and
dichloromethane extract. *e petroleum ether and chloro-
form fractions of C. papaya fruit and root assessed in vivo for
antimalarial activity against early P. berghei infection in mice
displayed pronounced chemosuppressive effect at P< 0.001.
Significant activities were observed in petroleum ether
fractions (61.78%) compared to 48.11% of chloroform
fraction [71]. *e synergistic effects displayed by the ad-
ministration ofC. papaya andV. amygdalina in ameliorating
plasmodium infection in mice showed significant result at
P< 0.05. *e oral administration significantly surged the
RBC and PCV renaissance when compared to the disease
control. *is underlined the importance of plants in con-
ventional therapy of malaria infection [68]. Ethanolic leaf
extract of C. papaya was appraised on chloroquine-sensitive
and chloroquine-resistant strains of P. falciparum. *e ex-
tracts significantly inhibited the activities of both plasmo-
dium strains with IC50 � 40.75%, 36.54%, 25.30%, and 18.0%
for chloroquine-sensitive and IC50 � 50.23%, 32.50%,
21.45%, and 23.12% for chloroquine-resistance plasmodium
strains [81].
Azadirachta indica. Azadirachta indica extract is ap-
praised to contain bioactive compounds which dictate its
potencies against P. vivax and P. falcifarum [82]. Ethanolic
leaf extracts assessed in vivo absolutely inhibited P. berghei
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Table 5: *e isolated compounds from medicinal plants used as antimalarial.
S/n Name of plant Phytochemical compounds Structure Reference














2 C. citratus Geranial
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OH
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weight [83]. *e in vivo antiplasmodial potency of aqueous
and ethanolic leaf extracts was examined in P. berghei-in-
fected BALB/c mice at dosage of 50 to 200mg/kg/day. Both
extracts exhibited significant antiplasmodial potency in a
dose-dependent technique which could be due to the active
antiplasmodial compounds screened [56].
4. Conclusion and Future Prospects
Malaria is a universal civic health peril, and recent drug
resistance of the parasite is a persistent concern. *is study
shows that a highly diverse set of native medicinal herbs is
currently used for the management of malaria in Nigeria.
Based on the results, there is substantial indication that the
traditional use of antimalarial medicinal plants by Yoruba
ethnics (studied areas) is driven by important therapeutic
agents, which could be elucidated structurally and further
established by in vitro or in vivo investigations. In recent
times, the growing interest in phytoremediation of malaria
led to the isolation and characterization of bioactive com-
pounds in medicinal plants (Table 5) *e isolation, char-
acterization, and quantification of these compounds were
appraised via chromatographic and spectrophotometric
methods. Likewise, different assays such as susceptibility
microassay technique [95], four day suppressive test [96],
96-well microtiter plate format SYBR green florescence assay
[97], and LDH method [98] are used to appraise the anti-
plasmodial potential of plant extracts (Table 4).
Several modes of preparation, usage factors, health risks,
and countermeasures on the use of antimalarial herbal drugs
should be systematically examined through advanced
scientific approaches. *is will aid in the identification and
authentication of therapeutic potency of antimalarial com-
pounds isolated from medicinal herbs, thereby promoting its
global relevance as efficacious and safe antimalarial plants in
primary health care. Individuals, societies, sociogroups, and
governmental and nongovernmental organizations should
devise plans which could assist in the conservation of these
medicinal plants in order to prevent their extermination and
exploitation of indigenous populations, as well as consider-
ations for cultural disruptions should one or more of these
plant species become a valuable resource. In the meantime,
the outcomes of this study serve as a platform of appraisal for
indigenous claims of medicinal plants as effective antimalarial
drugs in Nigeria and the world as a whole.
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[36] F. M. Talontsi, M. Lamshöft, C. Douanla-Meli, S. F. Kouam,
and M. Spiteller, “Antiplasmodial and cytotoxic dibenzofu-
rans from preussia sp. harboured in Enantia chlorantha oliv,”
Fitoterapia, vol. 93, pp. 233–238, 2014.
[37] F. F. Boyom, E. M. Kemgne, R. Tepongning et al., “Anti-
plasmodial activity of extracts from seven medicinal plants
used in malaria treatment in Cameroon,” Journal of Ethno-
pharmacology, vol. 123, no. 3, pp. 483–488, 2009.
[38] F. Tchoumbougnang, P. H. Zollo, E. Dagne, and
Y. Mekonnen, “In VivoAntimalarial activity of essential oils
from Cymbopogon citratus and Ocimum gratissimumon mice
infected withPlasmodium berghei,” Planta Medica, vol. 71,
no. 1, pp. 20–23, 2005.
[39] M. N. Shuaibu, P. A. Wuyep, T. Yanagi, K. Hirayama,
T. Tanaka, and I. Kouno, “*e use of microfluorometric
method for activity-guided isolation of antiplasmodial com-
pound from plant extracts,” Parasitology Research, vol. 102,
no. 6, pp. 1119–1127, 2008.
[40] D. V. Dapper, B. N. Aziagba, and O. O. Ebong, “Anti-
plasmodial effects of the aqueous extract of Phyllanthus
amarus Schumach and *onn against Plasmodium berghei in
Swiss albino mice,” Nigerian Journal of Physiological Science,
vol. 22, no. 1-2, pp. 19–25, 2010.
[41] J. Priyanka, L. Hingorani, and K. Nilima, “Pharmacodynamic
evaluation for antiplasmodial activity of Holarrhena anti-
dysentrica (Kutaja) and Azadirachta indica (Neemb) in
Plasmodium berghei infected mice model,” Asian Pacific
Journal of Tropical Medicine, vol. 6, no. 7, pp. 520–524, 2013.
[42] K. Murugan, C. Panneerselvam, C. Samidoss et al., “In vivo
and in vitro effectiveness of Azadirachta indica-synthesized
silver nanocrystals against Plasmodium berghei and Plasmo-
dium falciparum, and their potential against malaria mos-
quitoes,” Research in Veterinary Science, vol. 106, no. 14–22,
p. 42, 2016.
[43] F. I. D. Afolayan, O. M. Adegbolagun, B. Irungu, L. Kangethe,
J. Orwa, and C. I. Anumudu, “Antimalarial actions of Law-
sonia inermis, Tithonia diversifolia and Chromolaena odorata
in combination,” Journal of Ethnopharmacology, vol. 191,
pp. 188–194, 2016.
[44] O. T. Odugbemi, O. R. Akinsulire, I. E. Aibinu, and
P. O. Fabeku, “Medicinal plants useful for malaria therapy in
okeigbo, ondo state, southwest Nigeria,” African Journal of
Traditional Complementary Alternative Medicine, vol. 4, no. 2,
pp. 191–198, 2008.
[45] R. K. Cimanga, G. L. Tona, G. K.Mesia et al., “Bioassay-guided
isolation of antimalarial triterpenoid acids from the leaves
ofMorinda lucida,” Pharmaceutical Biology, vol. 44, no. 9,
pp. 677–681, 2006.
[46] B. Chithambo, X. S. Noundou, and R. W. M. Krause, “Anti-
malarial synergy of secondary metabolites from Morinda
lucida Benth,” Journal of Ethnopharmacology, vol. 199,
pp. 91–96, 2017.
[47] C. N. Muthaura, J. M. Keriko, C. Mutai et al., “Antiplasmodial
potential of traditional antimalarial phytotherapy remedies
used by the Kwale community of the Kenyan coast,” Journal of
Ethnopharmacology, vol. 170, pp. 148–157, 2015.
[48] E. O. Ajaiyeoba, O. O. Ogbole, O. O. Abiodun, J. S. Ashidi,
P. J. Houghton, and C. W. Wright, “Cajachalcone: an anti-
malarial compound from Cajanus cajan Leaf extract,” Journal
of Parasitology Research, vol. 2013, Article ID 703781, 5 pages,
2013.
[49] K. K. Ajibesin, B. A. Ekpo, D. N. Bala, E. E. Essien, and
S. A. Adesanya, “Ethnobotanical survey of akwa ibom state of
Nigeria,” Journal of Ethnopharmacology, vol. 115, no. 3,
pp. 387–408, 2008.
[50] J. Kayode andM. A. Omotoyinbo, “Ethnobotanical utilization
and conservation of chewing sticks plants species in Ekiti state
Nigeria,” Research Journal of Botany, vol. 4, no. 1, pp. 107–115,
2008.
[51] T. A. Tor-anyiin, R. Sha’ato, and H. O. Oluma, “Ethnobo-
tanical survey of anti-malarial medicinal plants amongst the
Tiv people of Nigeria,” Journal of Herbs Spices and Medicinal
Plants, vol. 10, no. 3, pp. 61–74, 2003.
[52] K. G. Ramawat and J. M. Merillon, Bioactive Molecules and
Medicinal Plants, Springer, Berlin, Germany, 2008.
[53] T. P. Devasagayam, J. C. Tilak, K. K. Boloor, K. S. Sane,
S. S. Ghaskadbi, and R. D. Lele, “Free radicals and antioxi-
dants in human health: current status and future prospects,”
Journal of Association of Physicians in India, vol. 52,
pp. 794–804, 2004.
[54] E. David-Oku, J. Obiajunwa-Otteh, G. Akuodor, and
A. Essien, “Evaluation of the antimalarial potential of Icacina
senegalensis juss (Icacinaceae),” Asian Pacific Journal of
Tropical Medicine, vol. 7, no. 1, pp. 469–472, 2014.
[55] S. O. Okere, J. O. Sangodele, E. Ogunwole, M. D. Adams, and
M. O. Shafe, “Antiplasmodial activity of aqueous leaf extract
of Cymbopogon citratus against Plasmodium falciparum in-
fected rats,” American Journal of Biomedical and Life Sciences,
vol. 2, no. 3, pp. 60–64, 2014.
[56] L. A. Oseni and G. M. Akwetey, “An in-vivo evaluation of
antiplasmodial activity of aqueous and ethanolic leaf extracts
of Azadirachta indica in Plasmodium berghei infected balb/c
mice,” International Journal of Pharmaceutical Science and
Research, vol. 3, no. 5, pp. 1406–1410, 2012.
[57] R. I. Mojirayo, “In vivo anti-plasmodial activity and histo-
pathological analysis of water and ethanol extracts of a pol-
yherbal antimalarial recipe,” Journal of Pharmacognosy and
Phytotherapy, vol. 9, no. 6, pp. 87–100, 2017.
[58] J. M. Agbedahunsi, A. O. Adepiti, A. A. Adedini,
O. Akinsomisoye, and A. Adepitan, “Antimalarial properties
of Morinda lucida and Alstonia booneion sulphadoxine-py-
rimethamine and Curcuma longaon quinine in mice,” Journal
of Herbs, Spices & Medicinal Plants, vol. 22, no. 1, pp. 1–10,
2016.
[59] Y. Hanifah, T. Suryawati, and G. Maryatun, “*e antimalarial
activity of the extract of the neem leaves (Azadirachta indica,
A. Juss) on Plasmodium falciparum in vitro,” in Proceedings of
the Annual International Conference Syiah Kuala University,
vol. 1, no. 1, Banda Aceh, Indonesia, 2011.
[60] J. O. Adebayo, K. E. Adewole, and A. U. Krettli, “Cysteine-
stabilised peptide extract of Morinda lucida (Benth) leaf
exhibits antimalarial activity and augments antioxidant de-
fense system in P. berghei- infected mice,” Journal of Eth-
nopharmacology, vol. 207, pp. 118–128, 2017.
[61] P. A. Ntonga, N. Baldovini, E. Mouray, L. Mambu, P. Belong,
and P. Grellier, “Activity of Ocimum basilicum, Ocimum
20 Scientifica
canum, and Cymbopogon citratus essential oils against Plas-
modium falciparum and mature-stage larvae of Anopheles
funestuss,” Parasite, vol. 21, p. 33, 2014.
[62] M. Farahna, S. Bedri, S. Khalid, M. Idris, C. R. Pillai, and
E. A. Khalil, “Anti-plasmodial effects of Azadirachta indica in
experimental cerebral malaria: apoptosis of cerebellar Pur-
kinje cells of mice as a marker,” North American Journal of
Medical Sciences, vol. 2, no. 11, pp. 518–525, 2010.
[63] A. C. Adebajo, S. A. Odediran, F. A. Aliyu, P. A. Nwafor,
N. T. Nwoko, and U. S. Umana, “In vivo antiplasmodial
potentials of the combinations of four Nigerian antimalarial
plants,” Molecules, vol. 19, pp. 13136–13146, 2014.
[64] I. S. Bello, T. Oduola, O. G. Adeosun, N. O. A. Omisore,
G. O. Raheem, and A. A. Ademosun, “Evaluation of anti-
malarial activity of various fractions of Morinda lucida leaf
extract and Alstonia boonei stem bark,” Global Journal of
Pharmacology, vol. 3, no. 3, pp. 163–165, 2009.
[65] U. M. Chukwuocha, O. Fernández-Rivera, and M. Legorreta-
Herrera, “Exploring the antimalarial potential of whole
Cymbopogon citratus plant therapy,” Journal of Ethno-
pharmacology, vol. 193, pp. 517–523, 2016.
[66] P. V. V. Satish, D. Santha Kumari, and K. Sunita, “Anti-
plasmodial efficacy of Calotropis gigantea (L.) against Plas-
modium falciparum (3D7 strain) and Plasmodium berghei
(ANKA),” Journal of Vector Borne Diseases, vol. 54, no. 3,
pp. 215–225, 2017.
[67] D. Arome, E. Chinedu, S. Ameh, and A. Sunday, “Compar-
ative antiplasmodial evaluation of Cymbopogon citratus ex-
tracts in Plasmodium berghei-infected mice,” Journal of
Current Research in Scientific Medicine, vol. 2, no. 1,
pp. 29–35, 2016.
[68] O. Okpe, N. Habila, J. Ikwebe, V. A. Upev, S. R. Okoduwa, and
O. T. Isaac, “Antimalarial potential of Carica papaya and
Vernonia amygdalina in mice infected with Plasmodium
berghe,” Journal of Tropical Medicine, vol. 2016, Article ID
8738972, 6 pages, 2016.
[69] P. A. Tarkang, F. A. Okalebo, L. S. Ayong, G. A. Agbor, and
A. N. Guantai, “Anti-malarial activity of a polyherbal product
(Nefang) during early and established Plasmodium infection
in rodent models,”Malaria Journal, vol. 13, no. 1, p. 456, 2014.
[70] G. Hintsa, G. G. Sibhat, and A. Karim, “Evaluation of anti-
malarial activity of the leaf latex and TLC isolates from Aloe
megalacantha baker in Plasmodium berghei infected mice,”
Evidence-Based Complementary and Alternative Medicine,
vol. 2019, Article ID 6459498, 9 pages, 2019.
[71] G. Zeleke, D. Kebebe, E. Mulisa, and F. Gashe, “In vivo an-
timalarial activity of the solvent fractions of fruit rind and root
of Carica papaya Linn (Caricaceae) against Plasmodium
berghei in mice,” Journal of Parasitology Research, vol. 2017,
Article ID 3121050, 9 pages, 2017.
[72] A. A. Olayode, O. S. Saka, O. C. Ajayi, and M. A. Agbaje,
“Activities of aqueous extracts of mangifera indica on para-
sitaemia level and blood profile of plasmodium berghei-in-
fected albino mice,” PharmaTutor, vol. 4, no. 4, pp. 36–42,
2016.
[73] C. I. Orabueze, D. A. Ota, and H. A. Coker, “Antimalarial
potentials of Stemonocoleus micranthus harms (legumino-
seae) stem bark in Plasmodium berghei infectedmice,” Journal
of Traditional and Complementary Medicine, vol. 10, no. 1,
pp. 70–78, 2019.
[74] E. I. O. Ajayi, M. A. Adeleke, T. Y. Adewumi, and
A. A. Adeyemi, “Antiplasmodial activities of ethanol extracts
of Euphorbia hirtawhole plant and Vernonia
amygdalinaleaves in Plasmodium berghei-infected mice,”
Journal of Taibah University for Science, vol. 11, no. 6,
pp. 831–835, 2017.
[75] G. C. Akuodor, A. G. Ahunna, E. M. Nwakaego,
C. K. Chimsorom, and A. E. Chile, “Antimalarial potential of
the ethanolic leaf extract of Pseudocedrala kotschyi,” Journal of
Acute Disease, vol. 4, no. 1, pp. 23–27, 2015.
[76] M. Gupta, U. Mazumder, P. Gomathi, and V. T. Selvan,
“Antimicrobial activity of methanol extracts of Plumeria
acuminata Ait,” Leaves and Tephrosia Purpurea (Linn.) Pers.
Roots” Natural Radiance, vol. 7, no. 2, pp. 102–105, 2008.
[77] T. Tcheghebe, N. Tatong, S. Armel, K. Justin, and N. Justin,
“Ethnobotanic survey of medicinal plants used for malaria
therapy in western Cameroon,” Journal of Medicinal Plant
Studies, vol. 4, no. 3, pp. 248–258, 2016.
[78] E. O. Agbaje and A. O. Onabanjo, “*e effects of extracts of
Enantia chloranthain malaria,” Annals of Tropical Medicine &
Parasitology, vol. 85, no. 6, pp. 585–590, 1991.
[79] R. L. van Zyl, A. M. Viljoen, and A. K. Jäger, “In vitro activity
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